MACLEODS PHARMACEUTICALS LTD
PharmaMACLEODS PHARMACEUTICALS LTD is a pharmaceutical company focused on Respiratory.
MACLEODS PHARMACEUTICALS LTD's Key Drugs
MACLEODS PHARMACEUTICALS LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MACLEODS PHARMACEUTICALS LTD's Recent FDA Approvals
New NDA/BLA approvals for MACLEODS PHARMACEUTICALS LTD over the last two years — novel drugs only, excluding generics and label supplements.
MACLEODS PHARMACEUTICALS LTD's Therapeutic Areas
MACLEODS PHARMACEUTICALS LTD's approved drugs and pipeline span 1 therapeutic area, led by Respiratory. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MACLEODS PHARMACEUTICALS LTD's Top Competitors
MACLEODS PHARMACEUTICALS LTD's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and GSK. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MACLEODS PHARMACEUTICALS LTD Pipeline Snapshot
MACLEODS PHARMACEUTICALS LTD has 1 active clinical program from ClinicalTrials.gov — 1 Phase 3, 0 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Respiratory pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 3